REGENERON PHARMACEUTICALS, INC. Deferred Tax Assets, Deferred Income
REGENERON PHARMACEUTICALS, INC. (REGN) had Deferred Tax Assets, Deferred Income of $0 as of 2022-12-31, per its 10-K filed 2023-02-06.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2023-02-06
- 2022-12-31: Deferred Tax Assets, Deferred Income $0.00.
- 2021-12-31: Deferred Tax Assets, Deferred Income $57.30M.
- 2020-12-31: Deferred Tax Assets, Deferred Income $44.60M.
- 2019-12-31: Deferred Tax Assets, Deferred Income $22.00M.
| Period end | Deferred Tax Assets, Deferred Income | Deferred Tax Assets, Deferred Income as first filed |
|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-06 | |
| 2021-12-31 | $57.30M 10-K · filed 2023-02-06 | |
| 2020-12-31 | $44.60M 10-K · filed 2022-02-07 | |
| 2019-12-31 | $22.00M 10-K · filed 2021-02-08 | |
| 2018-12-31 | $20.20M 10-K · filed 2020-02-07 | |
| 2017-12-31 | $102.40M 10-K · filed 2019-02-07 | $102.44M 10-K · filed 2018-02-08 |
| 2016-12-31 | $214.59M 10-K · filed 2018-02-08 | |
| 2015-12-31 | $51.77M 10-K · filed 2017-02-09 | |
| 2014-12-31 | $60.22M 10-K · filed 2016-02-11 | $75.50M 10-K · filed 2015-02-12 |
| 2013-12-31 | $88.03M 10-K · filed 2015-02-12 | |
| 2012-12-31 | $99.66M 10-K · filed 2014-02-13 | |
| 2011-12-31 | $120.49M 10-K · filed 2013-02-15 | |
| 2010-12-31 | $70.44M 10-K · filed 2012-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |